![](https://www.canaan.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBWk09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--52abb59fb25c5c4125d3abc56edb3666c2ee4249/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9VWTI5dFltbHVaVjl2Y0hScGIyNXpld2M2QzNKbGMybDZaVWtpQ1RVeE1sNEdPZ1pGVkRvSmRISnBiVlE9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--227fdc48d0cc0381319025b1f375233c6a320fb3/durata.png)
Durata Therapeutics
Durata is a biopharmaceutical company pursuing late-stage clinical development of novel antibiotic programs.
Partner
Brent AhrensInvestment
Series A
Durata is a biopharmaceutical company pursuing late-stage clinical development of novel antibiotic programs.
Series A